CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 12, 2022 · earnings

ORMP earnings: a positive outcome, +6.4%

On May 12, 2022, ORAMED PHARMACEUTICALS INC. reached its earnings. The result was a positive outcome, and the stock moved +6.4% in the window around the event. It had already run -36.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$3.89
1d before
$4.14
Event day
$4.57
1d after
$5.14
5d after

Pre-catalyst setup

-36.2%
30-day run-up
7747%
30-day volatility
2.1×
volume spike